Nyxoah (NYXH) Competitors $10.35 -0.05 (-0.48%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$10.33 -0.02 (-0.19%) As of 02/21/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NYXH vs. PLSE, LQDA, RXST, INMD, AORT, MDXG, BLFS, FNA, EMBC, and BBNXShould you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include Pulse Biosciences (PLSE), Liquidia (LQDA), RxSight (RXST), InMode (INMD), Artivion (AORT), MiMedx Group (MDXG), BioLife Solutions (BLFS), Paragon 28 (FNA), Embecta (EMBC), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry. Nyxoah vs. Pulse Biosciences Liquidia RxSight InMode Artivion MiMedx Group BioLife Solutions Paragon 28 Embecta Beta Bionics Pulse Biosciences (NASDAQ:PLSE) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership, dividends and community ranking. Is PLSE or NYXH more profitable? Pulse Biosciences has a net margin of 0.00% compared to Nyxoah's net margin of -1,043.93%. Nyxoah's return on equity of -51.68% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -96.89% -74.83% Nyxoah -1,043.93%-51.68%-40.11% Do analysts recommend PLSE or NYXH? Nyxoah has a consensus price target of $17.00, suggesting a potential upside of 64.25%. Given Nyxoah's stronger consensus rating and higher possible upside, analysts plainly believe Nyxoah is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nyxoah 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, PLSE or NYXH? Pulse Biosciences has higher earnings, but lower revenue than Nyxoah. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,711.13-$42.21MN/AN/ANyxoah$4.70M75.00-$46.77M-$1.87-5.53 Does the MarketBeat Community favor PLSE or NYXH? Pulse Biosciences received 209 more outperform votes than Nyxoah when rated by MarketBeat users. However, 71.70% of users gave Nyxoah an outperform vote while only 63.66% of users gave Pulse Biosciences an outperform vote. CompanyUnderperformOutperformPulse BiosciencesOutperform Votes24763.66% Underperform Votes14136.34% NyxoahOutperform Votes3871.70% Underperform Votes1528.30% Do institutionals and insiders believe in PLSE or NYXH? 77.0% of Pulse Biosciences shares are owned by institutional investors. 71.5% of Pulse Biosciences shares are owned by insiders. Comparatively, 17.1% of Nyxoah shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, PLSE or NYXH? Pulse Biosciences has a beta of 1.85, meaning that its share price is 85% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500. Does the media favor PLSE or NYXH? In the previous week, Nyxoah had 1 more articles in the media than Pulse Biosciences. MarketBeat recorded 3 mentions for Nyxoah and 2 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.34 beat Nyxoah's score of 0.15 indicating that Pulse Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nyxoah 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryPulse Biosciences and Nyxoah tied by winning 8 of the 16 factors compared between the two stocks. Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NYXH vs. The Competition Export to ExcelMetricNyxoahSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$354.23M$4.71B$5.85B$9.15BDividend YieldN/A39.90%4.76%3.85%P/E RatioN/A14.9116.5114.19Price / Sales75.0052.72450.0276.60Price / CashN/A51.1038.0134.95Price / BookN/A6.577.644.63Net Income-$46.77M$90.13M$3.18B$245.69M7 Day Performance-1.71%-2.20%-1.95%-2.68%1 Month Performance-0.38%-2.17%-0.23%-2.16%1 Year Performance-37.42%15.26%16.69%12.90% Nyxoah Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NYXHNyxoah2.8581 of 5 stars$10.35-0.5%$17.00+64.3%-32.1%$354.23M$4.70M0.00110PLSEPulse Biosciences1.4628 of 5 stars$22.36+2.7%N/A+108.2%$1.38B$700,000.000.00140News CoveragePositive NewsLQDALiquidia2.0541 of 5 stars$16.22+3.0%$25.38+56.4%+13.0%$1.37B$17.49M-9.9550RXSTRxSight2.6433 of 5 stars$32.06-3.0%$58.13+81.3%-46.2%$1.29B$89.08M-38.63220Upcoming EarningsINMDInMode1.9176 of 5 stars$18.54+2.8%$23.00+24.1%-9.3%$1.29B$394.82M7.89480Positive NewsAORTArtivion1.4458 of 5 stars$30.50-0.2%$31.80+4.3%+44.6%$1.28B$354M-1,524.751,500MDXGMiMedx Group3.0142 of 5 stars$8.35+0.5%$12.00+43.7%-1.0%$1.23B$321.48M15.18870BLFSBioLife Solutions1.7259 of 5 stars$25.91-0.7%$29.43+13.6%+52.4%$1.20B$143.27M-24.44440FNAParagon 282.0515 of 5 stars$13.09+0.5%$14.60+11.6%-4.2%$1.10B$216.39M-17.68343,000EMBCEmbecta4.807 of 5 stars$17.50+0.5%$23.00+31.4%-5.7%$1.02B$1.12B17.502,100Short Interest ↓BBNXBeta BionicsN/A$22.53-4.1%N/AN/A$965.64MN/A0.00294Analyst UpgradeNews Coverage Related Companies and Tools Related Companies Pulse Biosciences Competitors Liquidia Competitors RxSight Competitors InMode Competitors Artivion Competitors MiMedx Group Competitors BioLife Solutions Competitors Paragon 28 Competitors Embecta Competitors Beta Bionics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NYXH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NYXH Stock Alerts